The company, based in Germany, is combining an antibody targeted approach with amanitin, a unique toxin molecule originally identified in the death cap mushroom (Amanita phalloides). This new ...
Ladenburg, Germany, 21 March 2025 – Heidelberg Pharma AG (FSE: HPHA) today published its financial results and Annual Report for fiscal year 2024 (1 December 2023 – 30 November 2024) and its outlook ...